[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v14y1994i3p236-244.html
   My bibliography  Save this article

The Impact of Age on the Cost - Effectiveness of Hypertension Treatment

Author

Listed:
  • Magnus Johannesson
Abstract
The aim of this study was to investigate whether any consistent pattern exists with respect to the cost-effectiveness of hypertension treatment and age, based on the results of ran domized drug trials. Data about age, entry diastolic blood pressure, and relative risks of coronary heart disease (CHD) and stroke from 19 randomized trials were used to derive point estimates of the cost-effectiveness of each trial. The relationship between age and cost per life-year gained was then estimated by regression analysis, controlling for entry diastolic blood pressure. The regression analysis shows a statistically significant average decrease in the cost per life-year gained of about SEK 15,000 per year of older age for both men and women ($1 = SEK 6). Sensitivity analysis showed that the improvement in cost- effectiveness with age was stable towards various assumptions, but that the magnitude of the improvement varied greatly with the discount rate. Based on the results of randomized drug trials, it is concluded that the cost-effectiveness of hypertension treatment improves with patient age for both men and women. Key words: hypertension; drug treatment; cost- effectiveness; age; economic evaluation. (Med Decis Making 1994;14:236-244)

Suggested Citation

  • Magnus Johannesson, 1994. "The Impact of Age on the Cost - Effectiveness of Hypertension Treatment," Medical Decision Making, , vol. 14(3), pages 236-244, August.
    • Handle: RePEc:sae:medema:v:14:y:1994:i:3:p:236-244
    DOI: 10.1177/0272989X9401400305
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X9401400305
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X9401400305?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Gerdtham, Ulf-G., 1993. "The impact of aging on health care expenditure in Sweden," Health Policy, Elsevier, vol. 24(1), pages 1-8, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Monica Auteri & Guido Borà, 2017. "La spesa sanitaria delle Regioni in Italia - Saniregio2017," Working Papers CERM 01-2017, Competitività, Regole, Mercati (CERM).
    2. U.‐G. Gerdtham & M. Löthgren & M. Tambour & C. Rehnberg, 1999. "Internal markets and health care efficiency: a multiple‐output stochastic frontier analysis," Health Economics, John Wiley & Sons, Ltd., vol. 8(2), pages 151-164, March.
    3. Vitor Castro, 2017. "Pure, White and Deadly… Expensive: A Bitter Sweetness in Health Care Expenditure," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 1644-1666, December.
    4. Karlsson, Martin & Klohn, Florian, 2011. "Some notes on how to catch a red herring Ageing, time-to-death & care costs for older people in Sweden," Publications of Darmstadt Technical University, Institute for Business Studies (BWL) 77470, Darmstadt Technical University, Department of Business Administration, Economics and Law, Institute for Business Studies (BWL).
    5. Johansson, Lennarth, 1997. "Decentralisation from acute to home care settings in Sweden," Health Policy, Elsevier, vol. 41(Supplemen), pages 131-143, September.
    6. Karlsson, Martin & Klohn, Florian, 2011. "Some notes on how to catch a red herring - Ageing, time-to-death and care costs for older people in Sweden," HERO Online Working Paper Series 2011:6, University of Oslo, Health Economics Research Programme.
    7. Henriksson, Freddie & Hjortsberg, Catharina & Rehnberg, Clas, 1999. "Pharmaceutical expenditure in Sweden," Health Policy, Elsevier, vol. 47(2), pages 125-144, May.
    8. Ulf-G Gerdtham & Philip Clarke & Alison Hayes & Soffia Gudbjornsdottir, 2009. "Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data," PharmacoEconomics, Springer, vol. 27(1), pages 81-90, January.
    9. Johannesson, Magnus & Johansson, Per-Olov, 1996. "The economics of ageing: on the attitude of Swedish people to the distribution of health care resources between the young and the old," Health Policy, Elsevier, vol. 37(3), pages 153-161, September.
    10. Wickstrom, Jannie & Serup-Hansen, Niels & Kristiansen, Ivar Sonbo, 2002. "Future health care costs--do health care costs during the last year of life matter?," Health Policy, Elsevier, vol. 62(2), pages 161-172, November.
    11. Van Tielen, Rudy & Peys, Frank & Genaert, Jean, 1998. "The demographic impact on ambulatory pharmaceutical expenditure in Belgium," Health Policy, Elsevier, vol. 45(1), pages 1-14, July.
    12. Ethel Yiranbon & Zhou Lulin & Henry Asante Antwi & Emmanuel Opoku Marfo & Kwame Oduro Amoako & Daniel Kwame Offin, 2014. "Evaluating the Consequences of Ageing Population on Healthcare Cost to Ghana using Inflation-Adjusted Expenditure and Demographic Factors," International Journal of Academic Research in Accounting, Finance and Management Sciences, Human Resource Management Academic Research Society, International Journal of Academic Research in Accounting, Finance and Management Sciences, vol. 4(2), pages 282-290, April.
    13. Johannesson, Magnus & Johansson, Per-Olov, 1997. "Is the valuation of a QALY gained independent of age? Some empirical evidence," Journal of Health Economics, Elsevier, vol. 16(5), pages 589-599, October.
    14. Atella, Vincenzo & Conti, Valentina, 2014. "The effect of age and time to death on primary care costs: The Italian experience," Social Science & Medicine, Elsevier, vol. 114(C), pages 10-17.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:14:y:1994:i:3:p:236-244. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.